课题基金 / 基金详情

Signal integration of the death receptor pathways

Signal integration of the death receptor pathways
死亡受体途径的信号整合
批准号:
8237720
负责人:
XIAO-MING YIN
金额:
$15.49万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-20 至 2012-02-29

项目摘要

项目成果

XIAO-MING YIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The biology system is complicated in many senses, in particular regarding to the multiple pathways involved in initiating and regulating pathophysiological processes. We are interested in how different signaling events could interact with the cell death machinery important to these processes. In earlier studies, we defined the critical role of Bid, a pro-death Bcl-2 family protein, in the cross-talk between the death receptor pathway and the mitochondria pathway in a murine model of liver injury and hepatocyte apoptosis. We have since then found that novel signaling events are involved in the pathways, particularly when TNF-R1 is engaged. Based on our preliminary studies, we hypothesize that JNK and reactive oxygen species (ROS) are two important mechanisms that could integrate with the mitochondrial activation independently of Bid. We will address the function of JNK in promoting TNFa-induced hepatocyte apoptosis and liver injury (Aim 1) and how JNK may activate the mitochondria in a Bid-independent way (Aim 2). In Aim 3, we will investigate the role of ROS in TNFa induced liver injury and hepatocyte apoptosis, their regulation by the NF-KB pathway and how they may activate the mitochondria in a Bid-independent manner. A variety of approaches will be taken, including the in vivo models that utilize gene knockout mice and in vivo gene knockdown by RNAi, in vitro primary cell cultures and biochemistry analysis. While the focus of this proposal is at the integration of some of the key signaling processes at the mitochondria level following TNFa stimulation, our long-term goal is to understand how different signal pathways can be integrated to determine the final outcome of a pathological process, which would be important to the development of novel therapeutics.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1158/1535-7163.mct-08-1169
发表时间: 2009-07
期刊: Molecular cancer therapeutics
影响因子: 5.7
作者: [Ding WX, Ni HM, Gao W, Chen X, Kang JH, Stolz DB, Liu J, Yin XM]
通讯作者: Yin XM
DOI: 10.1016/j.bbrc.2011.03.067
发表时间: 2011-04-15
期刊: Biochemical and biophysical research communications
影响因子: 3.1
作者: [Kang JH, Li M, Chen X, Yin XM]
通讯作者: Yin XM
DOI: 10.1016/bs.mie.2016.10.024
发表时间: 2017
期刊: Methods in enzymology
影响因子: --
作者: [Li M, Fu Y, Yang Z, Yin XM]
通讯作者: Yin XM
DOI: 10.1038/s41598-018-32003-2
发表时间: 2018-09-10
期刊: Scientific reports
影响因子: 4.6
作者: [Liao Y, Li M, Chen X, Jiang Y, Yin XM]
通讯作者: Yin XM
10
    The Role of HMGB1 in autophagy deficiency-induced liver pathology
    • 批准号:
      10188516
    • 项目类别:
    • 资助金额:
      $40.04万
    • 财政年份:
      2018
    • 负责人:
      XIAO-MING YIN
    • 依托单位:
    The Role of HMGB1 in autophagy deficiency-induced liver pathology
    • 批准号:
      10137441
    • 项目类别:
    • 资助金额:
      $35.35万
    • 财政年份:
      2018
    • 负责人:
      XIAO-MING YIN
    • 依托单位:
    The Role of HMGB1 in autophagy deficiency-induced liver pathology
    Mechanism and role of selective autophagy in ethanol-induced liver injury
    海外基金